Programmed Death Ligand-1 Antagonists

Name
Programmed Death Ligand-1 Antagonists
Accession Number
DBCAT004242
Description

Not Available

Drugs
DrugDrug Description
AvelumabAn anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma.
DurvalumabAn antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer.
Drugs & Drug Targets
DrugTargetType
AvelumabProgrammed cell death 1 ligand 1target
DurvalumabProgrammed cell death 1 ligand 1target
DurvalumabProgrammed cell death protein 1target